Kbc Group Nv Vertex Pharmaceuticals Inc Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kbc Group Nv holds 96,727 shares of VRTX stock, worth $39.5 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

96,727

Previous 87,042 11.13%

Holding current value

$39.5 Million

Previous $40.8 Million 10.27%

% of portfolio

0.14%

Previous 0.12%

39 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$460.0 - $505.78 $4.46 Million - $4.9 Million	9,685 Added 11.13%	96,727 $45 Million
Q2 2024 Jul 17, 2024	BUY	$392.81 - $485.53 $1.91 Million - $2.36 Million	4,870 Added 5.93%	87,042 $40.8 Million
Q1 2024 May 08, 2024	SELL	$407.69 - $446.08 $7.79 Million - $8.52 Million	-19,102 Reduced 18.86%	82,172 $34.3 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $38.8 Million - $46.5 Million	-113,249 Reduced 52.79%	101,274 $41.2 Million
Q3 2023 Feb 15, 2024	SELL	$338.18 - $362.46 $39.4 Million - $42.2 Million	-116,478 Reduced 53.71%	100,400 $34.9 Million
Q2 2023 Feb 15, 2024	SELL	$314.42 - $351.91 $11.7 Million - $13.1 Million	-37,097 Reduced 14.61%	216,878 $76.3 Million
Q2 2023 Jul 28, 2023	BUY	$314.42 - $351.91 $7.73 Million - $8.65 Million	24,577 Added 12.94%	214,523 $75.5 Million
Q1 2023 Feb 14, 2024	SELL	$283.23 - $323.1 $17.6 Million - $20.1 Million	-62,249 Reduced 24.48%	192,078 $60.5 Million
Q1 2023 May 04, 2023	SELL	$283.23 - $323.1 $17.9 Million - $20.4 Million	-63,181 Reduced 24.96%	189,946 $59.8 Million
Q4 2022 Feb 14, 2024	SELL	$285.76 - $321.48 $10.2 Million - $11.5 Million	-35,649 Reduced 12.29%	254,327 $73.4 Million
Q3 2022 Feb 15, 2024	BUY	$273.83 - $305.53 $41.8 Million - $46.7 Million	152,701 Added 150.78%	253,975 $73.5 Million
Q3 2022 Nov 08, 2022	SELL	$273.83 - $305.53 $9.71 Million - $10.8 Million	-35,475 Reduced 12.29%	253,127 $73.3 Million
Q2 2022 Feb 14, 2024	BUY	$234.96 - $292.55 $2.71 Million - $3.38 Million	11,537 Added 4.14%	289,976 $81.7 Million
Q2 2022 Jul 26, 2022	BUY	$234.96 - $292.55 $2.39 Million - $2.97 Million	10,163 Added 3.65%	288,602 $81.3 Million
Q1 2022 Feb 14, 2024	SELL	$221.42 - $260.97 $67.9 Million - $80.1 Million	-306,815 Reduced 52.42%	278,439 $72.7 Million
Q1 2022 May 06, 2022	SELL	$221.42 - $260.97 $67.9 Million - $80.1 Million	-306,815 Reduced 52.42%	278,439 $72.7 Million
Q4 2021 Feb 14, 2024	BUY	$177.01 - $223.45 $85.7 Million - $108 Million	483,980 Added 477.89%	585,254 $129 Million
Q4 2021 Feb 03, 2022	BUY	$177.01 - $223.45 $54 Million - $68.2 Million	305,091 Added 108.9%	585,254 $129 Million
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $2.9 Million - $3.24 Million	-15,983 Reduced 5.4%	280,163 $50.8 Million
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $8.09 Million - $9.54 Million	43,132 Added 17.05%	296,146 $59.7 Million
Q1 2021 Apr 26, 2021	BUY	$207.02 - $241.31 $1.74 Million - $2.03 Million	8,418 Added 3.44%	253,014 $54.4 Million
Q4 2020 Feb 10, 2021	BUY	$207.01 - $276.09 $20 Million - $26.6 Million	96,378 Added 65.02%	244,596 $57.8 Million
Q3 2020 Oct 28, 2020	BUY	$255.65 - $303.1 $6.64 Million - $7.87 Million	25,969 Added 21.24%	148,218 $40.3 Million
Q2 2020 Aug 10, 2020	BUY	$225.48 - $295.8 $5.19 Million - $6.81 Million	23,009 Added 23.19%	122,249 $35.5 Million
Q1 2020 May 04, 2020	SELL	$199.77 - $247.81 $3.1 Million - $3.85 Million	-15,529 Reduced 13.53%	99,240 $23.6 Million
Q4 2019 Feb 11, 2020	SELL	$166.71 - $223.91 $80,187 - $107,700	-481 Reduced 0.42%	114,769 $25.1 Million
Q3 2019 Nov 07, 2019	BUY	$166.23 - $187.09 $3.38 Million - $3.8 Million	20,332 Added 21.42%	115,250 $19.5 Million
Q2 2019 Jul 30, 2019	BUY	$164.61 - $190.37 $3.13 Million - $3.62 Million	19,020 Added 25.06%	94,918 $0
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $12.4 Million - $14.8 Million	75,828 Added 108325.71%	75,898 $0
Q4 2018 Dec 03, 2019	SELL	$151.91 - $192.21 $9.54 Million - $12.1 Million	-62,795 Reduced 99.89%	70 $12,000
Q4 2018 Jan 31, 2019	BUY	$151.91 - $192.21 $9.54 Million - $12.1 Million	62,795 Added 89707.14%	62,865 $10.4 Million
Q3 2018 Dec 03, 2019	SELL	$167.73 - $192.74 $5.82 Million - $6.69 Million	-34,726 Reduced 99.8%	70 $13,000
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $5.82 Million - $6.69 Million	34,726 Added 49608.57%	34,796 $0
Q2 2018 Dec 03, 2019	SELL	$145.72 - $169.96 $3.54 Million - $4.13 Million	-24,307 Reduced 99.71%	70 $12,000
Q2 2018 Aug 03, 2018	BUY	$145.72 - $169.96 $3.54 Million - $4.13 Million	24,307 Added 34724.29%	24,377 $0
Q1 2018 Dec 03, 2019	SELL	$151.6 - $177.13 $2.95 Million - $3.45 Million	-19,473 Reduced 99.64%	70 $11,000
Q1 2018 May 09, 2018	SELL	$151.6 - $177.13 $482,846 - $564,159	-3,185 Reduced 14.01%	19,543 $0
Q4 2017 Feb 07, 2018	SELL	$137.28 - $155.55 $882,573 - $1 Million	-6,429 Reduced 22.05%	22,728 $0
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $4.32 Million - $4.73 Million	29,157	29,157 $0

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account